Literature DB >> 16139386

Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat.

Andreas Geier1, Christoph G Dietrich, Tobias Grote, Ulrich Beuers, Thomas Prüfer, Peter Fraunberger, Siegfried Matern, Carsten Gartung, Alexander L Gerbes, Manfred Bilzer.   

Abstract

BACKGROUND/AIMS: Alterations in hepatobiliary transporters may render fatty livers more vulnerable against various toxic insults.
METHODS: We therefore studied expression and function of key organic anion transporters and their transactivators in 8-week-old obese Zucker rats, an established model for non-alcoholic fatty liver disease.
RESULTS: Compared to their heterozygous littermates, obese animals showed a significant reduction in canalicular bile salt secretion, which was paralleled by significantly diminished Oatp2 mRNA and protein levels together with reduced nuclear HNF3beta, while expression of bile salt export pump, organic anion transporter (Oatp) 1 and multidrug resistance-associated protein (Mrp) 4 were unchanged. Impaired bile salt-independent bile flow in obese rats was associated with a 50% reduction of biliary secretion of the Mrp 2 model-substrates glutathione disulfide and S-(2,4-dinitrophenyl)glutathione. In line Mrp2 protein expression was reduced by 50% in obese rats.
CONCLUSIONS: Oatp2 and Mrp2 expression is decreased in fatty liver and may impair metabolism and biliary secretion of numerous xenobiotics. Reduction of bile salt secretion and absence of biliary GSH excretion may contribute to impaired bile flow and posthepatic disorders associated with biliary GSH depletion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139386     DOI: 10.1016/j.jhep.2005.05.031

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

1.  Obesity and its impact on drug therapy: are we ready for this change?

Authors:  Michael Neely; Stan Louie
Journal:  Clin Pharmacokinet       Date:  2011-12-01       Impact factor: 6.447

2.  Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.

Authors:  Johannes Schmitt; Bo Kong; Grace L Guo; Andreas Geier; Bruno Stieger; Oliver Tschopp; Simon M Schultze; Monika Rau; Achim Weber; Beat Müllhaupt
Journal:  Liver Int       Date:  2014-02-07       Impact factor: 5.828

3.  A direct comparison of methods used to measure oxidized glutathione in biological samples: 2-vinylpyridine and N-ethylmaleimide.

Authors:  Mitchell R Mcgill; Hartmut Jaeschke
Journal:  Toxicol Mech Methods       Date:  2015-10-13       Impact factor: 2.987

4.  Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.

Authors:  Sarah J Schrieber; Roy L Hawke; Zhiming Wen; Philip C Smith; K Rajender Reddy; Abdus S Wahed; Steven H Belle; Nezam H Afdhal; Victor J Navarro; Catherine M Meyers; Edward Doo; Michael W Fried
Journal:  Drug Metab Dispos       Date:  2011-08-24       Impact factor: 3.922

Review 5.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

6.  Pharmacokinetics of Hormonal Contraception in Individuals with Obesity: a Review.

Authors:  Shaalini Ramanadhan; William J Jusko; Alison Edelman
Journal:  Curr Obstet Gynecol Rep       Date:  2020-05-04

7.  Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress.

Authors:  Irina M Bochkis; Nir E Rubins; Peter White; Emma E Furth; Joshua R Friedman; Klaus H Kaestner
Journal:  Nat Med       Date:  2008-07-27       Impact factor: 53.440

8.  Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.

Authors:  Craig D Fisher; Andrew J Lickteig; Lisa M Augustine; Ronald P J Oude Elferink; David G Besselsen; Robert P Erickson; Nathan J Cherrington
Journal:  Eur J Pharmacol       Date:  2009-04-07       Impact factor: 4.432

Review 9.  Altered Expression of Transporters, its Potential Mechanisms and Influences in the Liver of Rodent Models Associated with Diabetes Mellitus and Obesity.

Authors:  Leilei Ma; Lei He; Le Wang; Li Li; Xuena Lin; Guoyu Pan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-06       Impact factor: 2.441

10.  Foxa2-dependent hepatic gene regulatory networks depend on physiological state.

Authors:  Irina M Bochkis; Jonathan Schug; Nir E Rubins; Atul R Chopra; Bert W O'Malley; Klaus H Kaestner
Journal:  Physiol Genomics       Date:  2009-05-05       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.